Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.75 |
| ▸ | RECQL | P46063 | 1/20 | 0.74 |
| ▸ | MEN1 | O00255 | 4/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | MAPT | P10636 | 1/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | METAP2 | P50579 | 2/20 | 0.59 |
| ▸ | METAP1 | P53582 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | SLC16A3 | O15427 | 5/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1428546 | 0.86 | RECQL (1.00) | KMT2ARECQLMEN1ALDH1A1MAPT | |
| SCHEMBL7537943 | 0.83 | RECQL (0.76) | KMT2ARECQLMEN1ALDH1A1MAPT | |
| SCHEMBL15798169 | 0.82 | KMT2A (0.73) | KMT2ARECQLMEN1ALDH1A1MAPT | |
| SCHEMBL11584443 | 0.82 | KMT2A (0.70) | KMT2ARECQLMEN1ALDH1A1MAPT | |
| SCHEMBL28745665 | 0.80 | KMT2A (0.63) | KMT2ARECQLMEN1ALDH1A1MAPT | |
| SCHEMBL16127963 | 0.80 | ALDH1A1 (0.69) | KMT2AMEN1ALDH1A1LMNAMETAP2 | |
| SCHEMBL7578880 | 0.80 | KEAP1 (0.76) | KMT2ARECQLMEN1ALDH1A1MAPT | |
| SCHEMBL164503 | 0.80 | RECQL (0.76) | KMT2ARECQLMEN1ALDH1A1MAPT | |
| SCHEMBL7573136 | 0.80 | KEAP1 (0.76) | KMT2ARECQLMEN1ALDH1A1MAPT | |
| SCHEMBL29958089 | 0.79 | RECQL (0.74) | KMT2ARECQLMEN1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1304924-A2 | COMPOSITIONS FOR REPELLING CRAWLING INSECTS | Bayer Aktiengesellschaft (DE) | 2003-05-02 | — | — | EP | disclosed |
| US-20020094993-A1 | Compositions for repelling crawling insects | S.C. JOHNSON & SON, INC. | 2002-07-18 | — | — | US | disclosed |
| WO-2002005646-A2 | COMPOSITIONS FOR REPELLING CRAWLING INSECTS | S.C. JOHNSON & SON, INC. (US) (US) | 2002-01-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020094993-A1 | Compositions for repelling crawling insects | ACHE, DDT, GAP43 | KMT2A 3439/4885RECQL 3669/4885MEN1 3828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.